NeuroSense Therapeutics Ltd. Shareholders to Vote on Auditor Appointment at Upcoming Annual General Meeting
NeuroSense Therapeutics Ltd. will hold its Annual General Meeting on September 25, 2025, in Herzliya, Israel, where shareholders will vote on the appointment of auditors. The Board of Directors recommends voting in favor of this proposal. Shareholders of record as of August 22, 2025, can vote in person or by proxy. More details are available on the company's Investor Relations website.
NeuroSense Therapeutics Ltd. has announced its upcoming Annual General Meeting of Shareholders, scheduled for September 25, 2025, at its Herzliya offices in Israel. The primary proposal on the agenda is the appointment of auditors. The Board of Directors recommends a vote in favor of this proposal. Shareholders of record as of August 22, 2025, are entitled to vote either by attending the meeting or via proxy. Additional details and materials are available on the company’s Investor Relations website. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-079411), on August 21, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
